Back to results
US 9,040,690 B2Granted
2,3,5-trisubstituted thiophene compounds and uses thereof
AssigneeNovartis AG
InventorsDavid Barnes, Scott Louis Cohen, Jiping Fu, Lei Shu, Rui Zheng
Life of this patent
Estimating the term…
Abstract
The present invention provides a compound of formula I: a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.
Claims13
A compound of formula (I):
- or a salt thereof, wherein
- m is 0, 1 or 2;
- n is 0 or 1, wherein m+n is 1, 2 or 3;
- R1 is C3-C10alkynyl or phenyl, which phenyl is substituted with 0, 1, 2, or 3 substituents which are independently selected from the group consisting of halogen, hydroxy, cyano, C1-C4alkyl, haloC1-C4alkyl and C1-C4alkoxy, and which alkynyl is optionally substituted with a C3-C7cycloalkyl substituent, which cycloalkyl is optionally substituted with 1 or 2 independently selected C1-C4alkyl groups;
- R2 is CO2H or C(O)N(H)S(O)2CH3;
- R3 is C3-C7cycloalkyl which is substituted with 0, 1, 2 or 3 halogen atoms;
- R3a represents 0, 1, 2, 3 or 4 residues independently selected at each occurrence from the group consisting of hydroxy, amino, cyano, halogen, C1-C6alkyl, and C1-C6alkoxy, wherein each alkyl or alkoxy substituent is substituted with 0, 1 or 2 substituents independently selected from hydroxy, cyano, C1-C4alkoxy, C1-C4alkylsulfone, N(R3b)2, C(O)N(R3b), heterocycle having 4 to 7 ring atoms and 1 or 2 ring heteroatoms selected from N, O and S and 5 or 6 member heteroaryl;
- or two geminal R3a substituents, taken in combination form a spirocyclic 3 to 6 member cycloalkyl or heterocycle;
- R3b is independently selected at each occurrence from hydrogen, C1-C4alkyl, C1-C4alkoxyC1-C4alkyl and C1-C4alkanoyl;
- or N(R3b)2, taken in combination, form a 4 to 6 member heterocycle having 0 or 1 additional ring heteroatoms selected from N, O and S;
- X is O, N-L-R4 or CR5R6;
- L is a bond, S(O)2 or C(O);
- R4 is C1-C6alkyl or C3-C7cycloalkyl each of which is substituted with 0, 1, or 2 hydroxy and 0 or 1 substituents selected from cyano, S(O)2—C1-C4alkyl, CO2H or NR4aR4b or phenyl;
- R4 is naphthyl or phenyl, which phenyl is substituted with 0, 1, 2, or 3 substituents independently selected form the group consisting of halogen, cyano, C1-C6alkyl, haloC1-C6alkyl, C1-C6alkoxy, haloC1-C6alkoxy, amino, hydroxy, mono- and di-C1-C6alkylamino, hydroxyC1-C4alkyl, aminoC1-C4alkyl, C1-C6alkyl-OC(O)NH—, C1-C4alkyl-C(O)NH—, —C(O)NR4aR4b, phenyl, phenoxy, heteroaryl having one or two ring nitrogen atoms and having 0, 1, or 2 C1-C4alkyl substituents, or two substituents combine to form a fused heterocyclic ring, which heterocycle has 5, 6 or 7 ring atoms, 1 or 2 ring heteroatoms selected from N, O and S and which heterocycle is substituted with 0, 1 or 2 substituents independently selected from C1-C6alkyl;
- or
- R4 is a 5 or 6 member heteroaryl having 1 to 3 heteroatoms selected from N, O and S, which heteroaryl is substituted with 0, 1, or 2 substituents independently selected from the group consisting of halogen, cyano, C1-C6alkyl, haloC1-C6alkyl, C1-C6alkoxy, haloC1-C6alkoxy, hydroxy, NR4aR4b, hydroxyC1-C4alkyl, aminoC1-C4alkyl, C1-C6alkyl-OC(O)NH—, C3-C7cycloalkyl, C5-C7cycloalkenyl, phenyl, 5 or 6 membered heteroaryl having 1 or 2 ring heteroatoms selected from N, O and S, and saturated or partially unsaturated monocyclic or bicyclic heterocycle which heterocycle has 1 or 2 ring N, O or S atoms, 5 to 7 ring atoms in each ring and is substituted with 0, 1 or 2 substituents independently selected from the group consisting of halogen, C1-C6alkyl, C1-C6alkanoyl, C1-C6alkoxyC(O)N(H)CH2, aminoC1-C4alkyl, C1-C4alkoxyC1-C4alkyl and NR4aR4b, and wherein the phenyl or heteroaryl substituent is unsubstituted or substituted with 1 or 2 independently selected substituents selected from halogen, CO2H, cyano, C1-C4alkyl, C1-C4alkoxy, CH2NR4aR4b and C(O)NR4aR4b;
- or
- R4 is a saturated heterocycle having 1 ring nitrogen and 0 or 1 additional ring heteroatom selected from N, O and S, which heterocyclic ring is substituted with 0, 1, or 2 substituents independently selected from the group consisting of C1-C6alkyl, CO2C1-C6alkyl and CO2-benzyl;
- R4a is independently selected at each occurrence from the group consisting of hydrogen and C1-C6alkyl, wherein the alkyl substituent is unsubstituted or substituted with hydroxy, C1-C4alkoxy, amino or mono- and di-C1-C4alkylamino;
- R4b is independently selected at each occurrence from the group consisting of hydrogen, C1-C6alkyl and C1-C4alkanoyl, wherein the alkyl substituent is unsubstituted or substituted with hydroxy, C1-C4alkoxy, amino or mono- and di-C1-C4alkylamino;
- or
- NR4aR4b, taken in combination, form a heterocyclic ring having one ring nitrogen atom and 0 or 1 additional ring heteroatom selected from N, O and S, which heterocyclic ring is substituted with 0, 1, 2 or 3 substituents independently selected from the group consisting of halogen, hydroxy, amino, C1-C4alkyl, haloC1-C4alkyl, hydroxyC1-C4alkyl, aminoC1-C4alkyl, C1-C4alkoxy, C1-C4alkoxyC1-C4alkyl, and mono- and di-C1-C4alkylamino;
- R5 is absent or is selected from the group consisting of hydrogen and C1-C6alkyl;
- R6 is oxo, hydrogen, hydroxy, amino, N(H)-J-R7;
- J is absent, C(O) or S(O)2;
- and
- R7 is C1-C6alkyl, phenyl or benzyl, each of is optionally substituted with C1-C6alkyl, C1-C6alkoxy, halogen, phenyl or phenoxy.
24 more elements
Dependencies are inferred from the claim text.